| |
| |
|
| Insider
Information: |
Barron Hal |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
34,922 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
34,922 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2010-01-26 |
34,922 |
2009-01-22 |
0 |
Premium* |
|
|
Juno Therapeutics, Inc. |
JUNO |
Director |
2018-03-05 |
0 |
2014-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-03-05 |
4 |
D |
$87.00 |
$328,860 |
D/D |
(3,780) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-03-05 |
4 |
D |
$87.00 |
$8,700,000 |
D/D |
(100,000) |
3,780 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
336 |
103,780 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
361 |
103,444 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
516 |
103,083 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
698 |
102,567 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
768 |
101,869 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
101,101 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
328 |
100,663 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
335 |
100,335 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2014-12-23 |
4 |
B |
$24.00 |
$2,400,000 |
D/D |
100,000 |
100,000 |
2.39 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2010-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
18,908 |
34,922 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2009-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,014 |
16,014 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
